Prot# F7ICH-1641: Randomised, Double-Blind, Placebo Controlled, Multi-Centre, Parallel Groups Confirmatory Efficacy & Safety Trial of Activated Recombinant Factor VII (NovoSeven®/Niastase®) in Acute Intracerebral Hemorrhage (Phase 3a)

Project: Research project

Project Details

StatusFinished
Effective start/end date12/12/05 → 8/8/07

Funding

  • Novo Nordisk Inc. (F7ICH-1641)